Robert Clark, MD, conducts basic and translational research in the areas of inflammatory response and oxidative stress, including the cell biology and biochemistry of phagocytic cells. His work has contributed to the fundamental understanding of the phagocyte NADPH oxidase (NOX2) system, including the generation of reactive oxygen species, its transcriptional and post-translational component regulation, and the genetics and biochemistry of NOX2 deficiency. More recently, he has been researching the role of inflammation in the biology of aging, with a focus on central nervous system inflammation and neurodegenerative disorders, including Parkinson’s disease. He was also a key contributor in BioMedSA’s Clinical Trial Taskforce.
Dr. Clark is the Assistant VP of Clinical Research at UT Health San Antonio, the Edward LeWinn Professor of Medicine and Director of the Stevens Foundation Parkinson’s Disease Center of Excellence. Previously, he was the Chair of Medicine at UT Health San Antonio. He is an elected member of the Association of American Physicians and the American Society of Clinical Investigation, a Fellow of the Infectious Diseases Society of America and the American Association for the Advancement of Science, and a Master of the American College of Physicians. He received his M.D. from Columbia University and post-doctoral training at NIH and the University of Washington.